SCHEMBL629901

SCHEMBL629901

C=C(C)C(=O)OCCOCCOCCOCCOCCO

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.68
TSHR P16473 9/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 6/20 0.40
TP53 P04637 2/20 0.39
HIF1A Q16665 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 2/20 0.38
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPT P10636 1/20 0.38
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804854 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL863839 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL9860990 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
Di(Hydroxyethyl)Ether SCHEMBL18317889 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL2809295 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
Tetraethylene Glycol SCHEMBL8659912 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL33376 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL2367411 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL864145 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1
SCHEMBL61385 1.00 THRB (0.68) THRBTSHRMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150335568-A1 RADIATION-CURABLE, STABLE NAIL GEL COMPOSITIONS AND METHODS OF PREPARATION AND USE MYCONE DENTAL CORPORATION (US) 2015-11-26 US claimed
EP-2863883-A1 RADIATION-CURABLE, STABLE NAIL GEL COMPOSITIONS AND METHODS OF PREPARATION AND USE Mycone Dental Supply Company Inc. (US) 2015-04-29 EP claimed
WO-2013192515-A1 RADIATION-CURABLE, STABLE NAIL GEL COMPOSITIONS AND METHODS OF PREPARATION AND USE MYCONE DENTAL SUPPLY COMPANY, INC. (US) 2013-12-27 WO claimed
US-8329845-B2 Divided redox-curing type composition KURARAY NORITAKE DENTAL INC. (JP) 2012-12-11 US claimed
US-7855242-B2 Dental resin composition, method of manufacture, and method of use thereof PENTRON CLINICAL TECHNOLOGIES LLC (US) 2010-12-21 US claimed
US-7275933-B2 Method of manufacturing dental restorations PENTRON CLINICAL TECHNOLOGIES, LLC (US) 2007-10-02 US claimed
US-20070049656-A1 DENTAL RESIN COMPOSITION, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF PENTRON CLINICAL TECHNOLOGIES, INC (US) 2007-03-01 US claimed
US-20040249015-A1 Method of manufacturing dental restorations KERR CORPORATION 2004-12-09 US claimed
US-6787584-B2 BIODEGRADABLE MACROMONOMER HAVING TERMINAL ACRYLATE OR METHACRYLATE GROUP(S) (ACRYLATED POLYLACTONE); A CURING COMPOSITION; A FILLER OF BIOACTIVE GLASS, APATITES, AND OTHER (METH)ACRYLATES PENTRON CORPORATION 2004-09-07 US claimed
WO-2002078646-A1 DENTAL COMPOSITIONS PENTRON CORPORATION (US) 2002-10-10 WO claimed
US-6455608-B1 CURABLE DENTAL FORMULATION COMPRISING DEGRADABLE MACROMONOMERS HAVING ONE OR MORE TERMINAL ACRYLATE OR METHACRYLATE FUNCTIONALITY, A CURING AGENT; PREPARING A SITE TO BE RESTORED IN A TOOTH AND APPLYING ABOVE FORMULATION JENERIC/PENTRON INCORPORATED 2002-09-24 US claimed
US-20020120033-A1 Biodegradable macromonomer having terminal acrylate or methacrylate group(s) (acrylated polylactone); a curing composition; a filler of bioactive glass, apatites, and other (meth)acrylates KERR CORPORATION 2002-08-29 US claimed
EP-1202701-A1 DENTAL COMPOSITIONS COMPRISING DEGRADABLE POLYMERS JENERIC/PENTRON Incorporated (US) 2002-05-08 EP claimed
WO-2001012129-A1 DENTAL COMPOSITIONS COMPRISING DEGRADABLE POLYMERS JENERIC/PENTRON INCORPORATED (US) 2001-02-22 WO claimed
EP-0313665-B1 ACTINIC RADIATION-CURABLE COMPOSITION FOR CAST POLYMERIZATION AND PRODUCT OF CAST POLYMERIZATION MITSUBISHI RAYON CO., LTD. (JP) 1993-02-03 EP claimed
US-4985472-A ACRYLATED POLYISOCYANATE MITSUBISHI RAYON COMPANY, LTD. (JP) 1991-01-15 US claimed
EP-0313665-A1 ACTINIC RADIATION-CURABLE COMPOSITION FOR CAST POLYMERIZATION AND PRODUCT OF CAST POLYMERIZATION MITSUBISHI RAYON CO., LTD. (JP) 1989-05-03 EP claimed
CN-122094989-A Polymer, water repellent, fiber product and method for producing fiber product 2026-05-26 CN disclosed
EP-0218229-A2 Thermoplastic resin composition and process for its preparation DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1987-04-15 EP disclosed
US-4170582-A Process for preparing a polymer resin aqueous dispersion DAINIPPON INK AND CHEMICALS, INC. (JP) 1979-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049656-A1 DENTAL RESIN COMPOSITION, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF CAD, MMAB, DNMT3A THRB 1953/4885TSHR 4073/4885MEN1 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.